Timothy Perren
Impact in
- Reproductive Medicine top 0.2%
- Ovarian cancer diagnosis and treatment
- Oncology top 0.5%
- Cancer Treatment and Pharmacology
- HER2/EGFR in Cancer Research
- PARP inhibition in cancer therapy
Papers in
-
- Ovarian cancer diagnosis and treatment 69
- Oncology 61
- Cancer Treatment and Pharmacology 21
- HER2/EGFR in Cancer Research 12
- Co-authors
- Peter J. Selby (17 shared papers)Gordon C. Jayson (14 shared papers)P Selby (11 shared papers)Rosamonde E. Banks (7 shared papers)Sean Kehoe (5 shared papers)Matthew Nankivell (5 shared papers)Jane Hook (8 shared papers)Mahesh Parmar (3 shared papers)
- Journals
- British Journal of Cancer (23 papers)Journal of Clinical Oncology (23 papers)Annals of Oncology (17 papers)European Journal of Cancer (7 papers)Cancer Chemotherapy and Pharmacology (5 papers)
- Partner nations
- United KingdomCanadaAustralia
In The Last Decade
Timothy Perren
148 papers receiving 6.4k citations
Timothy Perren's Hit Papers
Peers
Comparison fields: 5 of 145
- Reproductive Medicine 2.2k
- Oncology 3.0k
- Obstetrics and Gynecology 855
- Cancer Research 873
- Pathology and Forensic Medicine 806
Countries citing papers authored by Timothy Perren
This map shows the geographic impact of Timothy Perren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Timothy Perren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Timothy Perren more than expected).
Fields of papers citing papers by Timothy Perren
This network shows the impact of papers produced by Timothy Perren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Timothy Perren. The network helps show where Timothy Perren may publish in the future.
Co-authors
The 25 scholars most cited alongside Timothy Perren, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 151 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): an open-label, randomised, controlled, non-inferiority trial Hit paper breakdown → | 2015 | 945 |
| 2 | 2007 | 399 | |
| 3 | 1999 | 286 | |
| 4 | Vascular endothelial growth factor (VEGF) in breast cancer: comparison of plasma, serum, and tissue VEGF and microvessel density and effects of tamoxifen. | 2000 | 286 |
| 5 | 1993 | 254 | |
| 6 | 2011 | 208 | |
| 7 | 1987 | 191 | |
| 8 | 2011 | 164 | |
| 9 | 2016 | 164 | |
| 10 | 1997 | 126 | |
| 11 | 2016 | 121 | |
| 12 | 2005 | 120 | |
| 13 | 1991 | 117 | |
| 14 | 1998 | 111 | |
| 15 | 1995 | 107 | |
| 16 | 2003 | 103 | |
| 17 | 2001 | 96 | |
| 18 | 2013 | 95 | |
| 19 | 2007 | 82 | |
| 20 | 2016 | 76 |
About Timothy Perren
Timothy Perren is a scholar working on Reproductive Medicine, Oncology, Pulmonary and Respiratory Medicine, Surgery and Pathology and Forensic Medicine, having authored 151 papers that have together received 6.6k indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (69 papers), Intraperitoneal and Appendiceal Malignancies (28 papers), Cancer Treatment and Pharmacology (21 papers), Breast Cancer Treatment Studies (20 papers), Renal cell carcinoma treatment (14 papers), HER2/EGFR in Cancer Research (12 papers), Endometrial and Cervical Cancer Treatments (11 papers) and Lymphoma Diagnosis and Treatment (10 papers). The work is most often cited by research in Reproductive Medicine (2.2k citations), Oncology (3.0k citations), Obstetrics and Gynecology (855 citations), Cancer Research (873 citations) and Pathology and Forensic Medicine (806 citations). Timothy Perren has collaborated with scholars based in United Kingdom, Canada and Australia. Frequent co-authors include Peter J. Selby, Gordon C. Jayson, P Selby, Rosamonde E. Banks, Sean Kehoe, Matthew Nankivell, Jane Hook, Mahesh Parmar, David Luesley and Sharadah Essapen. Their work appears in journals such as British Journal of Cancer, Journal of Clinical Oncology, Annals of Oncology, European Journal of Cancer and Cancer Chemotherapy and Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.